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Revascularization of an occluded brachiocephalic
vein using Outback-LTD re-entry catheter
Gopinathan Anil, MD, FRCR, and Manish Taneja, MD, FRCR, Singapore
A 78-year-old man with end-stage renal disease and a right brachial-cephalic upper arm direct hemodialysis access
presented with symptomatic central venous occlusion. The right brachiocephalic vein occlusion in this patient was
refractory to wire traversal. Sharp recanalization of the central venous occlusion was done with an Outback LTD re-entry
catheter (Cordis Corporation, a Johnson & Johnson Company, Miami, Fla). The track was balloon dilated and stented.
When the conventional management options fail, this technique may be used to salvage a precious dialysis access and to
relieve the patient from symptoms of central venous hypertension. (J Vasc Surg 2010;52:1038-40.)CASE REPORT
A 78-year-old diabetic male with end-stage renal disease for 6
years presented with debilitating symptoms of central venous
hypertension (severe edema of ipsilateral upper extremity, upper
chest, neck, and face with venous eczema causing venous ulcers
and blisters). Review of the recent and previous venograms iden-
tified a recurrent and chronic occlusion of the entire right brachio-
cephalic vein (RBCV) and contiguous central part of the right
subclavian vein. The superior vena cava (SVC) and the rest of the
right subclavian vein were patent (Fig 1). He was being dialyzed
through a nontunneled right femoral vein hemodialysis catheter as
the occlusion precluded the use of his autogenous right brachial-
cephalic upper arm direct access. Prior attempts at crossing the
occlusion at other institutes had failed. There was a pacemaker lead
inserted from the left side with left subclavian vein stenosis. Rele-
vant history included hemodialysis through central venous cathe-
ters for more than 2 years, successful percutaneous transluminal
venoplasty (PTV) for RBCV occlusion involving the same site as
now followed by a symptom-free period of 20months, and comor-
bidities such as coronary artery disease, diabetes, and cardiac
rhythm abnormalities.
Attempts at percutaneous revascularization of the occluded
vein using standard catheter and guidewire techniques, both from
the arm (through both cephalic and basilic veins) and the groin
failed twice. None of the collaterals were robust enough to be
dilated as a replacement to the occluded RBCV. Hence, sharp
recanalization with the Outback LTD vascular re-entry catheter
(Cordis Corporation, a Johnson & Johnson Company, Miami,
Fla) was performed. The off-label use of the Outback and risks
involved (mediastinal hemorrhage was the chief concern) were
discussed with the referring nephrologist and vascular surgeon,
and an informed consent was obtained from the patient as well as
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1038his relatives. Before proceeding, a CT of the thorax taken a couple
of weeks ago was reviewed to gauge the extravascular mediastinal
anatomy. There was excessive fibrosis along the expected course of
the occluded RBCV and the vessel could not be identified separate
from mediastinal soft tissue.
The Outback LTD was introduced over a 300-cm-long,
0.014-inch guidewire (PT,2 Boston Scientific, Miami, Fla)
through the right brachial vein (as it was in a straight line with
the occlusion, compared to the cephalic vein). A transfemorally
inserted 4F Head Hunter catheter (Cordis Corporation, Miami,
Fla) was kept at the cranial end of the SVC, as a target for
navigating the re-entry catheter. Digital substraction angiogra-
phy ‘road-maps’ were also used to locate the patent vein, central
to occlusion. With biplanar fluoroscopy guidance, the radio-
opaque ‘L’ocator marker of the Outback was oriented toward
the SVC and the catheter was advanced in the proposed direc-
tion. As it encountered resistance, the 22-gauge nitinol needle
was let to exit the patent medial end of the right subclavian vein
and burrow through the fibrosed mediastinum, with continuous
gentle forward push on the entire catheter assembly. Simulta-
neously, the 0.014-inch guidewire was advanced through the nee-
dle (Fig 2, A). Once the wire entered the SVC (wire flows freely
within the vessel lumen), the needle was retracted and the
catheter withdrawn; the wire was grasped with En-snare (8-15
mm, Medtech, Davie, Fla) and pulled out through the femoral
access. This confirmed the intraluminal location of wire and
avoided the potential mishap of dissecting the vena cava. With
‘body-floss’ established, the revascularized track was predilated
with a 4-  40-mm balloon (Sterling, Boston Scientific Corpo-
ration, Maple Grove, Minn) and widened with a 12-  40-mm
balloon (Powerflex, Cordis Europa, Roden, The Netherlands).
Before predilatation with the larger balloon, the 0.014-inch
guidewire was exchanged for a 0.035-inch stiff guidewire
(Amplatz Super-Stiff, Boston Scientific, Natick, Mass). Sub-
sequently, a 14-  60-mm, self-expanding, nitinol stent
(SMART, Cordis Corporation, Miami, Fla) was deployed without
bridging the opening of the cephalic or left brachiocephalic veins.
The completion venograms demonstrated free antegrade transit of
contrast without mediastinal extravasation (Fig 2, B). The collat-
erals decompressed immediately. Hemodialysis through the right
arm access was initiated 2 days later. The edema and pain from
venous hypertension subsided over the next 2 to 3 days. At
1-month follow-up, the venous ulcers had healed. The hemodial-
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DISCUSSION
In patients with end-stage renal disease on hemodialy-
sis, central veno-occlusive disease due to hemodynamic
stress and intimal injury related to previous catheterization
is well-known1,2; rare causes include extrinsic compression
Fig 1. These digital subtraction angiography (DSA) im
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pacemaker lead; SVC, superior vena cava.
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obstruction.
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a surgical bypass may be attempted. In our patient, the
occlusion was refractory to wire traversal, medical risks did
not permit major surgery, and left subclavian vein stenosis
with an indwelling pacemaker lead precluded the reversal of
the fistula-bearing extremity.
The concept of sharp recanalization has been described
before. Ferral et al6 directed a 21-gauge needle percutane-
ously, toward a transfemorally inserted loop-snare, for ve-
nous catheter insertion in the presence of jugular and
subclavian occlusions. A similar method was used by Ath-
reya et al7 to insert tunneled dialysis catheters. Murphy et
al8 recanalized subclavian occlusion with a Rosch-Uchida
needle directed toward an inflated balloon, central to the
occlusion, through the axillary vein. Similarly, Honnef et
al9 used a TIPS needle (Cook, Bjaeverskov, Denmark) for
revascularization of an occluded left brachiocephalic vein.
Farrell et al10 and Lang et al11 did sharp recanalization in
the cephalad direction, toward a target placed in the patent
vein peripheral to the occlusion. However, our technique
and the selection of hardware are unique with no prior
references.
The Outback LTD is a single-lumen, over-the-wire, 6F
sheath-compatible catheter with a curved nitinol cannula
within the outer shaft running the full length of the catheter
to serve as the guidewire lumen.12 It is designed to facilitate
rapid and controlled passage into the true lumen after
subintimal guidewire passage during arterial recanalization
procedures.13 The nosecone at the catheter tip has an
‘L’-shaped radio-opaque marker (‘L’ocator ) indicating
needle direction. When the image intensifier is orthogo-
nally moved, a ‘T’-shape (tune) checks whether the cathe-
ter is overlying the vessel.12 The curved needle tip is de-
ployed from the catheter’s lateral exit port into the vessel
lumen using the proprietary ‘locate,’ ‘tune,’ and deploy
technique. We extrapolated the same principle to the ve-
nous side. As there was a need to retrace a long curved path
from the right subclavian vein into the SVC, we were biased
against the use of stiff needles. In comparison, the Out-
back-LTD with its flexible nature, torquability, and curved
geometry of the needle tip was preferred for traversing the
occlusion along a gentle arc. Continuous wire access is
another useful feature of this catheter. An alternative op-
tion of a radiofrequency-powered guidewire was consid-
ered but not exercised due to the lack of experience with itsuse and uncertainty of its safety in the presence of pace-
maker leads.
The approach described in this report may be used as a
revascularization technique, with due precautions for cen-
tral venous occlusions, refractory to conventional methods.
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